Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies.
Jaya BatraErsilia M DeFilippisStephanie GolobKevin J ClerkinVeli K TopkaraMarlena V HabalSusan RestainoJan M GriffinSun Hi LeeFarhana LatifMaryjane A FarrGabriel T SayerJayant RaikelkarNir UrielPublished in: Circulation. Heart failure (2022)
Prevalence of PTM in HT recipients nearly tripled over the past 2 decades. Patients with hematologic PTM were at increased risk of early mortality after HT. Patients with PTM were also at higher risk for posttransplant malignancy. Guidelines that reflect contemporary oncological care are needed to inform care of this heterogenous and expanding group of individuals.